Sarcomere gene variants did not improve cardiac function in pediatric patients with dilated cardiomyopathy from Japanese cohorts
Hirono, K.; Hata, Y.; Ichimata, S.; Nishida, N.; Imamura, T.; Asano, Y.; Kuramoto, Y.; Tsuboi, K.; Takarada, S.; Okabe, M.; Nakaoka, H.; Ibuki, K.; Ozawa, S.; Muneuch, J.; Yasuda, K.; Urayama, K.; Oka, H.; Miyamoto, T.; Baba, K.; Kato, A.; Saiki, H.; Kuwahara, N.; Harada, M.; Baba, S.; Morikawa, M.; Iwasaki, H.; Hirata, Y.; Ito, Y.; Sakaguchi, H.; Urata, S.; Toda, K.; Kittaka, E.; Okada, S.; Hasebe, Y.; hoshino, s.; Fujii, T.; Mitsushita, N.; Nii, M.; Ogino, K.; Fujino, M.; Yoshida, Y.; Fukuda, Y.; Iwashima, S.; Takigiku, K.; Sakata, Y.; Inuzuka, R.; Maeda, J.; Hayabuchi, Y.; Fujioka, T.; Nami
Show abstract
BackgroundDilated cardiomyopathy (DCM) is a progressive myocardial disorder characterized by impaired cardiac contraction and ventricular dilation. Some patients with DCM could manifest improvement in these abnormalities called left ventricular reverse remodeling (LVRR). However, the detailed association between genotypes and clinical outcomes, including LVRR, particularly among pediatric patients, remains uncertain. MethodsWe prospectively enrolled pediatric patients with DCM from Japanese multi-institutional centers between 2014 and 2023. We identified DCM-related genes and explored the association between gene variants and clinical outcomes, including LVRR, which was defined as any increase in left ventricular ejection fraction during the observation period. ResultsA total of 123 pediatric patients (62 males; mean age of 8 months [range, 1-51 months]) were retrospectively enrolled. There were 50 pathogenic variants in 45 patients (35.0%). The most identified gene was MYH7 (14.0%), followed by RYR2 (12.0%), and TPM1 (8.0%). A novel variant in the CASZ1 gene (NM_001079843.2 c.3356G>A, p. Trp1119Ter) was identified. LVRR was achieved in 47.5% of patients. In patients with sarcomere gene variants, the left ventricular ejection fraction remained unchanged (31.4% to 39.8%, P = 0.1913), whereas it significantly increased in patients with non-sarcomere gene variants (33.4% to 47.8%, P = 0.0466) and in patients without gene variants (33.6% to 54.1%, P = 0.003). ConclusionsPediatric patients with DCM exhibited a marked genetic heterogeneity with a different landscape from adults with DCM. LVRR was not uniform across functional gene groups, opening the door to tailor-made gene-guided prediction in pediatric patients with DCM. Clinical perspectiveO_ST_ABSWhat is new?C_ST_ABSO_LIYounger patients had predominance for DCM and risk factors for survival. C_LIO_LILVRR occurrence was lower in the sarcomere gene group, and cardiac function failed to improve. C_LI What are the clinical implications?O_LILVRR was not uniform across functional gene groups, which opens the door to the adoption of an individualized prediction approach in DCM according to the genetic features. C_LI
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Relationship of mild to moderate impairment of left ventricular ejection fraction with fatal ventricular arrhythmic events in cardiac sarcoidosis 96%
- Hypertrophic Cardiomyopathy -- The Impact of Age at Diagnosis of the Proband on Genetic Yield, Clinical Presentation, Outcomes, and Yield of Family Screening 96%
- An International Longitudinal Natural History Study of Danon Disease Patients: Unique Cardiac Trajectories Identified Based on Sex and Heart Failure Outcomes 94%
Similar papers in this journal
- Fragmented QRS is independently predictive of long-term adverse clinical outcomes in Asian patients hospitalized for heart failure: a retrospective cohort study 95%
- Electrocardiographic Abnormalities and Troponin Elevation in COVID-19 94%
- Autologous cardiac micrografts as support therapy to coronary artery bypass surgery 94%
Similar papers in this journal
- Prevalence and disease expression of pathogenic and likely pathogenic variants associated with inherited cardiomyopathies in the general population 97%
- Natural History, Phenotype Spectrum and Clinical Outcomes of Desmin ( DES )-Associated Cardiomyopathy 96%
- ALPK3 heterozygous truncating variants cause late-onset hypertrophic cardiomyopathy with frequent apical involvement and apical aneurysm 96%
Similar papers in this journal
- Competing Risks in Patients with Primary Prevention Implantable Cardioverters Defibrillators: Global Electrical Heterogeneity and Clinical Outcomes (GEHCO) Study 94%
- Early Experience with Ivabradine for Focal Atrial Tachycardia in Pediatric Patients with Congenital Heart Disease 93%
- Right bundle branch pacing: criteria, characteristics and outcomes 92%
Similar papers in this journal
- Association of the medical therapy with beta-blockers or inhibitors of renin-angiotensin system with clinical outcomes in patients with mildly reduced left ventricular ejection fraction after acute myocardial infarction 95%
- Decreased door-to-balloon time in patients with ST-segment elevation myocardial infarction during the early COVID-19 pandemic in South Korea – an observational study 91%
- Right ventricular contractility decreases during exercise in patients with non-advanced idiopathic pulmonary fibrosis 90%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.